You just read:

INCIVO® (telaprevir) Receives European Commission Approval for Twice Daily Dosing for Treatment of Genotype-1 Chronic Hepatitis C Virus (HCV)

News provided by

Janssen Infectious Diseases-Diagnostics BVBA

31 May, 2013, 09:28 BST